Dr. Stephanie Y. Lu, MD

Dr. Lu practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Lu's NPI, 1346420437, was assigned on November 6, 2007. Dr. Lu graduated from UC San Diego School of Medicine in 2004. Dr. Lu's California license number on file is A93439.

Dr. Lu's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Lu's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. Dr. Lu is also affiliated with Providence St. Jude Medical Center. The medical group on file is UCI Health Family Health Center, Anaheim. Dmand AI also links Dr. Lu to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lu practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Lu's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Lu is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Lu has a license on file in California.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, dry eye, eye infection or inflammation, glaucoma, hypertensive retinopathy and inflammation of iris among the conditions Dr. Lu treats.

CMS data shows 4,383 Medicare services from Dr. Lu across 8 procedure codes in 2024, for 990 Medicare patients. Medicare paid $227,117 for them.

CMS counts 990 Medicare patients who saw Dr. Lu in 2024. The largest group is 75 to 84, with 416 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lu's median patient age at 69, with 55% women.

In 2024, Dr. Lu wrote 404 Medicare Part D claims for 126 patients. 53% of them were for generic drugs. CMS names the drug for 313 of them, across 11 drugs with 11 or more claims each, at $58,219 in total drug cost. In 2023, CMS named 323 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Lu for performance year 2024, reported through an alternative payment model (APM). Dr. Lu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 19 procedures of cataract surgery by Dr. Lu, more than 43% of the clinicians it reports for that procedure.

Dmand AI links 9 papers to Dr. Lu, published from 2014 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Macular Degeneration and Mitochondria. Dr. Lu's most frequent co-authors are Baruch D. Kuppermann, MD, Anthony Bart Nesburn, MD and Daniela Annenelie Bota, MD.

CMS Open Payments shows 57 general payments to Dr. Lu from 17 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 49% of the total. Allergan Inc. paid the most, $2,904.

Dmand AI lists 1 award for Dr. Lu.

Dr. Lu graduated from UC San Diego School of Medicine in 2004. Dr. Lu is a member of AAO.

Dr. Lu is in network with 15 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.